Hussman Strategic Advisors, Inc. Corcept Therapeutics Inc Transaction History

Hussman Strategic Advisors, Inc.

$386 Million
Q3 2024

A detailed history of Hussman Strategic Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 42,000 shares of CORT stock, worth $2.19 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

42,000

Previous 105,000 60.0%

Holding current value

$2.19 Million

Previous $3.41 Million 43.07%

% of portfolio

0.5%

Previous 0.97%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$29.51 - $46.26 $1.86 Million - $2.91 Million	-63,000 Reduced 60.0%	42,000 $1.94 Million
Q2 2024 Aug 01, 2024	BUY	$22.21 - $34.48 $466,410 - $724,079	21,000 Added 25.0%	105,000 $3.41 Million
Q1 2024 May 01, 2024	BUY	$21.1 - $27.46 $664,650 - $864,990	31,500 Added 60.0%	84,000 $2.12 Million
Q4 2023 Feb 01, 2024	SELL	$24.82 - $32.88 $260,610 - $345,240	-10,500 Reduced 16.67%	52,500 $1.71 Million
Q3 2023 Nov 07, 2023	SELL	$21.97 - $33.8 $672,282 - $1.03 Million	-30,600 Reduced 32.69%	63,000 $1.72 Million
Q2 2023 Aug 03, 2023	SELL	$21.44 - $25.15 $385,920 - $452,700	-18,000 Reduced 16.13%	93,600 $2.08 Million
Q1 2023 May 04, 2023	BUY	$19.2 - $24.47 $357,120 - $455,142	18,600 Added 20.0%	111,600 $2.42 Million
Q4 2022 Feb 08, 2023	SELL	$19.95 - $29.96 $618,450 - $928,760	-31,000 Reduced 25.0%	93,000 $1.89 Million
Q3 2022 Nov 02, 2022	SELL	$24.7 - $29.12 $382,850 - $451,360	-15,500 Reduced 11.11%	124,000 $3.18 Million
Q2 2022 Sep 12, 2022	BUY	$17.33 - $25.3 $1.52 Million - $2.21 Million	87,500 Added 168.27%	139,500 $3.32 Million
Q4 2021 Jan 31, 2022	SELL	$17.1 - $23.34 $1.76 Million - $2.4 Million	-103,000 Reduced 66.45%	52,000 $1.03 Million
Q3 2021 Nov 01, 2021	BUY	$19.68 - $22.53 $1.22 Million - $1.4 Million	62,000 Added 66.67%	155,000 $3.05 Million
Q2 2021 Aug 03, 2021	BUY	$19.97 - $24.43 $419,370 - $513,030	21,000 Added 29.17%	93,000 $2.05 Million
Q1 2021 May 03, 2021	SELL	$23.49 - $30.56 $1.68 Million - $2.19 Million	-71,500 Reduced 49.83%	72,000 $1.71 Million
Q4 2020 Feb 01, 2021	SELL	$16.78 - $27.3 $1.87 Million - $3.04 Million	-111,500 Reduced 43.73%	143,500 $3.75 Million
Q3 2020 Nov 02, 2020	BUY	$12.46 - $19.98 $934,500 - $1.5 Million	75,000 Added 41.67%	255,000 $4.44 Million
Q2 2020 Jul 31, 2020	BUY	$11.0 - $18.26 $286,000 - $474,760	26,000 Added 16.88%	180,000 $3.03 Million
Q1 2020 May 01, 2020	BUY	$10.11 - $14.04 $520,664 - $723,060	51,500 Added 50.24%	154,000 $1.83 Million
Q4 2019 Jan 31, 2020	BUY	$12.06 - $16.96 $496,920 - $698,819	41,204 Added 67.22%	102,500 $1.24 Million
Q3 2019 Oct 31, 2019	BUY	$10.41 - $14.66 $638,091 - $898,599	61,296 New	61,296 $866,000
Q3 2018 Oct 31, 2018	SELL	$12.27 - $15.65 $1.53 Million - $1.96 Million	-125,000 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$15.3 - $19.69 $1.91 Million - $2.46 Million	125,000 New	125,000 $1.97 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.59B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Corcept Therapeutics Inc Transaction History